Suggestions
Rachel Happe
I am passionate about designing community-centric organizations that reward the best in people by connecting, energizing, and empowering them.
Rachel Happe is a collaborative leader with a diverse background in organizational, business, and community strategy.
She is known for her expertise in strategy, design, technology, governance, analytics, and management systems.
As the founder of Engaged Organizations and The Community Roundtable, Rachel has demonstrated her leadership in change management and entrepreneurship.
With a BA in Politics from Mount Holyoke College, Rachel Happe has had an impressive career journey through various key roles in companies and organizations.
Her leadership style is characterized by directness, collaboration, and empowerment, emphasizing authentic relationships, mentoring, inclusion, and team development.
Rachel's industry advocacy focuses on community, collaboration, and digital workplace practices, translating market trends into actionable business, product, and operational strategies.
Highlights
I have been dealing with prescription drug shortages all year. Then it happened to a second prescription.
For many people this has been going on for years, with the excuse that it was a COVID supply chain issue… but I believe that was the convenient “excuse” to decrease the supply of generic drugs.
PBMs - Pharmacy Benefit Managers - are causing much of the issue and they are monopolistic. 3 of them control 80% of the market. 6 control 96% of the market.
Not only that, PBMs are owned by the same companies that own medical insurers. CVS owns a huge medical insurer (Aetna), a PBM (Caremark), its pharmacy business, and provider services (Minute Clinic).
In the ADHD space they are marking up the price of drugs as much as 24x and not sharing that profit with manufacturers, which would incentivize more production. The PBMs are likely doing it to maximize their revenues from brand name drugs, for which they make a larger profit.
With insulin, which is life threatening, they could not restrict supply so that ratcheted up prices to obscene levels. President Biden has put price caps on that and other drugs for seniors but the issue still exists.
These companies have manufactured the pharmaceutical crisis. We are all paying the price.
Please consider writing to your federal and state representatives about this.
I don’t think enough politicians are paying attention to this problem and instead they are paying way too much time trying to control my uterus - which does not need fixing.
Here is a report from the FTC about this issue:
So fun catching up with two of the OG community managers this week - Rachel Luxemburg and Joe Pishgar and hearing about what they are still learning.
A little older, hopefully wiser, and still committed to the idea that including people in creating solutions is powerful.
